A forum for researchers, students and applicants in the field of cyclodextrin technology
During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the investigational antiviral
Hundreds of coronavirus patients have been treated with Gilead’s experimental Ebola treatment under an FDA program to allow access to
The novel coronavirus SARS-CoV-2 is affecting 65 countries and territories around the world with almost 90,000 reported cases and almost
Gilead Sciences, Inc. yesterday announced the initiation of two Phase 3 clinical studies to evaluate the safety and efficacy of
Much has already been written about PFAS. But when it comes to the behavior of PFAS in groundwater, there’s less
Bacteria are single-celled prokaryotic microorganisms, that means they do not have a true nucleus, mitochondria, or any other membrane-bound organelle
Cyclo Therapeutics, Inc. a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC)
Nanozymes are nanomaterials with enzyme-like properties. These artificial enzymes have emerged more robust than the natural enzymes and find applications
I would like to draw your attention to a very recent desperate approach for taking advantage of one’s naivety and
